CODMAN Siphonguard CSF Control Device - Valve, hydrocephalic
Access comprehensive regulatory information for CODMAN Siphonguard CSF Control Device - Valve, hydrocephalic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Integra Neurosciences Pty Ltd, manufactured by Integra LifeSciences Production Corporation in United States of America. The device registration started on March 02, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The SIPHONGUARD device can be used as a component of hydrocephalus shunt systems designed to shunt CSF from the lateral ventricles of the brain into the peritoneal cavity or right atrium of the heart. The SIPHONGUARD device is designed to reduce the potential hazards of excessive lowering of intraventricular pressure (with respect to atmospheric pressure) when a patient is in an erect position.